Literature DB >> 22249444

Gynecological cancer: True progress in ovarian cancer or just the tip of the iceberg?

Lisa Hutchinson.   

Abstract

Entities:  

Year:  2012        PMID： 22249444     DOI： 10.1038/nrclinonc.2011.210

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study.

Authors:  Walter H Gotlieb; Frederic Amant; Suresh Advani; Chanchal Goswami; Hal Hirte; Diane Provencher; Naresh Somani; S Diane Yamada; Jean-Francois Tamby; Ignace Vergote
Journal:  Lancet Oncol       Date:  2011-12-20       Impact factor: 41.316
  1 in total
  1 in total

1.  Identification of hub genes and key pathways associated with the progression of gynecological cancer.

Authors:  Xi Zhang; Yudong Wang
Journal:  Oncol Lett       Date:  2019-10-18       Impact factor: 2.967
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.